摘要
目的:观察艾灸“得气”对阿尔茨海默病(Alzhemier’s disease, AD)模型大鼠的疗效及脑内β淀粉样蛋白(Aβ)转运和降解相关酶蛋白表达的影响,探讨其改善认知功能的分子机制。方法:将60只SPF级SD雄性大鼠随机分为空白组(8只)、假手术组(8只)和造模组(44只),造模组采用双侧脑室注射Aβ1-42建立AD模型。38只造模成功的大鼠随机取8只作为模型组,剩余大鼠于“大椎”穴行温和灸,每天1次,每次40 min,共28 d。根据“得气”出现与否及出现早晚分为艾灸得气组(12只)、艾灸迟发得气组(10只)和艾灸非得气组(8只)。干预后各组大鼠行Morris水迷宫试验检测认知功能;HE染色观察大鼠脑组织形态;Western blot法检测大鼠海马Aβ及其受体介导转运相关蛋白[低密度脂蛋白受体相关蛋白(LRP)1、高级糖化终产物受体(RAGE)、载脂蛋白E(Apo E)]和降解相关酶[中性内肽酶(NEP)、胰岛素降解酶(IDE)、内皮素转换酶(ECE)-1和血管紧张素转换酶(ACE)2]的蛋白表达。结果:与假手术组比较,模型组逃避潜伏期延长(P<0.01),平台穿越次数、平台象限与总时间之比减少(P<0.01);脑组织损伤较重;海马Aβ、RAGE蛋白表达升高(P<0.01),海马LRP1、Apo E、NEP、IDE、ECE-1、ACE2蛋白表达降低(P<0.01)。与模型组比较,艾灸得气组逃避潜伏期缩短(P<0.05,P<0.01),艾灸迟发得气组和艾灸非得气组第2~5天逃避潜伏期缩短(P<0.05,P<0.01),艾灸得气组和艾灸迟发得气组平台穿越次数、平台象限与总时间之比增加(P<0.01,P<0.05);各艾灸组脑损伤均减轻,其中艾灸得气组损伤程度最轻,艾灸迟发得气组次之,艾灸非得气组稍有改善;各艾灸组Aβ、RAGE蛋白表达均降低(P<0.01,P<0.05),LRP1、IDE蛋白表达升高(P<0.01,P<0.05),艾灸得气组和艾灸迟发得气组Apo E蛋白表达升高(P<0.01,P<0.05),艾灸得气组NEP表达增加(P<0.05),艾灸得气组、艾灸迟发得气组ECE-1和ACE2蛋白表达增加(P<0.05)。与艾灸迟发得气组、艾灸非得气组比较,艾灸得气组第3~5天逃避潜伏期缩短(P<0.05),平台穿越次数、平台象限与总时间之比增加(P<0.05,P<0.01);与艾灸非得气组比较,艾灸得气组Aβ降低(P<0.05),LRP1和Apo E蛋白表达升高(P<0.05);艾灸得气组NEP表达高于艾灸迟发得气组、艾灸非得气组(P<0.05)。结论:艾灸“得气”较非“得气”能更好地促进Aβ转运和降解,从而降低脑内Aβ水平,改善AD模型大鼠认知功能。
Objective To observe the clinical effect of moxibustion with deqi on Alzheimer’s disease(AD) rats, and evaluate its effect on β-amyloid(Aβ) transport and enzymatic degradation proteins, to explore its molecular mechanism for improving cognitive function. Methods Sixty SPF-grade male SD rats were randomly divided into a blank group(8 rats), a sham-operation group(8 rats) and a model establishment group(44 rats). The rats in the model establishment group were injected with Aβ1-42 at bilateral ventricles to establish AD model. Among the 38 rats with successful model establishment, 8 rats were randomly selected as the model group, and the remaining rats were treated with mild moxibustion at "Dazhui"(GV 14), once a day, 40 min each time, for 28 days. According to whether deqi appeared and the occurrence time of deqi, the rats were divided into a deqi group(12 rats), a delayed deqi group(10 rats) and a non-deqi group(8 rats). After the intervention, the Morris water maze test was applied to evaluate the cognitive function;the HE staining was applied to observe the brain morphology;the Western blot method was applied to measure the protein expression of Aβ and its receptor mediated transport [low-density lipoprotein receptor-related protein(LRP) 1, receptor for advanced glycation end products(RAGE), apolipoprotein E(Apo E)] and enzymatic degradation [neprilysin(NEP), insulin degrading enzyme(IDE), endothelin converting enzyme(ECE)-1 and angiotensin converting enzyme(ACE) 2]. Results Compared with the sham-operation group, in the model group, the escape latency was prolonged(P<0.01), and the times of platform crossing and the ratio of platform quadrant to total time were reduced(P<0.01);the brain tissue was seriously damaged;the expression of hippocampal Aβ and RAGE was increased(P<0.01), and the expression of hippocampal LRP1, Apo E, NEP, IDE, ECE-1 and ACE2 was decreased(P<0.01). Compared with the model group, the escape latency was shortened in the deqi group(P<0.05, P<0.01), and the escape latency in the delayed deqi group and the non-deqi group was shortened from Day 2 to Day 5(P<0.05, P<0.01), and the times of platform crossing and the ratio of platform quadrant to total time were increased in the deqi group and the delayed deqi group(P<0.01, P<0.05);the brain damage in each moxibustion group was reduced, which was smallest in the deqi group, followed by the delayed deqi group and the non-deqi group;the expression of Aβ and RAGE was decreased(P<0.01, P<0.05) and the expression of LRP1 and IDE was increased in each moxibustion group(P<0.01, P<0.05);the expression of Apo E was increased in the deqi group and the delayed deqi group(P<0.01, P<0.05);the expression of NEP was increased in deqi group(P<0.05), and the expression of ECE-1 and ACE2 was increased in the deqi group and the delayed deqi group(P<0.05). Compared with the delayed deqi group and the non-deqi group, the escape latency in the deqi group was shortened from Day 3 to Day 5(P<0.05), and the times of platform crossing and the ratio of platform quadrant to total time were increased(P<0.05, P<0.01). Compared with the non-deqi group, the expression of Aβ was reduced(P<0.05), the expression of LRP1 and Apo E was increased in the deqi group(P<0.05). The expression of NEP in the deqi group was higher than that in the delayed deqi group and the non-deqi group(P<0.05). Conclusion Compared with non-deqi, moxibustion with deqi could promote Aβ transport and degradation, thereby reducing Aβ level in the brain and improving cognitive function for AD rats.
作者
吕志迈
黄丹丹
谢丁一
岳瑞珍
王金伟
罗蔚锋
陈日新
LV Zhi-mai;HUANG Dan-dan;XIE Ding-yi;YUE Rui-zhen;WANG Jin-wei;LUO Wei-feng;CHEN Ri-xin(Department of Neurology,First Affiliated Hospital of Gannan Medical College,Ganzhou 341000,Jiangxi Province,China;Department of Neurology,Second Affiliated Hospital of Suzhou University,Suzhou 215004,Jiangsu Province;Ganzhou Key Laboratory of Noninvasive Neuromodulation,Ganzhou 341000,Jiangxi Province;School of Basic Medicine,Gannan Medical College;Department of Acupuncture and Moxibustion,Affiliated Hospital of Jiangxi University of CM,Nanchang 330006)
出处
《中国针灸》
CAS
CSCD
北大核心
2022年第8期899-906,共8页
Chinese Acupuncture & Moxibustion
基金
国家重点基础研究发展(“973”)计划项目:2015CB554503
江西省2011协同创新中心:灸疗研究与临床转化协同创新中心。
关键词
阿尔茨海默病
艾灸
穴
大椎
得气
Aβ受体介导转运
Aβ降解相关酶
Alzheimer’s disease(AD)
moxibustion
Point GV 14(Dazhui)
deqi
Aβreceptor mediated transport
Aβenzymatic degradation